Hugo Biotech
Beijing
About Hugo Biotech
Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first class hospitals in china.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $124.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2022)
- Website: hugobiotech.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hugo-biotech-131560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.